MSLP.OB, CYAN, & RELV: MSLP recieves a contract from PSI Distribution a supplement distributor

July 30, 2010 - PRLog -- MusclePharm® Corporation

MusclePharm’s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside™. Headquartered in Denver, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists. In addition, the products have been field-tested by more than 100 elite professional athletes from the NFL, MMA, MLB and elsewhere. To date, the company has developed eight products: ASSAULT®, BATTLE FUEL®, BULLET PROOF®, COMBAT POWDER®, RECON®, SHRED MATRIX®, and MUSCLEGEL®. Two additional products are due in stores in 2010. MusclePharm products offer up to twice as much of the active ingredients per serving as competing products and incorporate a proprietary mix of ingredients not available elsewhere, such as Suma root– the “Russian Secret.” Suma is a natural, performance-boosting, strength-and muscle-building herbal derivative that has been used for years by top Russian athletes.

MusclePharm® Corporation is a fast-growing nutritional supplement company with a proprietary formulation used in eight performance products, they have reported to announce an exclusive distribution contract with PSI Distribution, a leading supplement distributor in Australia and New Zealand.

The exclusive and noteworthy contract will be worth $2 million in annual sales, allowing MusclePharm to expand into the Australian market and continue to grow as an international brand.

Included in the exclusive agreement with PSI is a combined opening purchase order of $500,000 dollars in MusclePharm products, which will begin shipping out in August. From there, a minimum Purchase Order of $500,000 in MusclePharm products will be made by PSI every 90 days, allowing MusclePharm to cultivate awareness in an area that has exploded in Ultimate Fighting Championship (UFC) and Mixed Martial Arts popularity.

(Source: CLICK HERE)

_________________________________




Cyanotech Corporation (Nasdaq Capital Market: CYAN),

Cyanotech Corporation is a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica® all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's spirulina, FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use as a food ingredient, augments energy and immune response. BioAstin's benefits derive from its superior antioxidant activity and from its ability to fight free radical damage and combat ongoing oxidative stress, enhancing skin, muscle and joint health.* Cyanotech produces these products from microalgae grown at its 90-acre facility in Hawaii using patented and proprietary technology and distributes them to nutritional supplement, nutraceutical and cosmeceutical makers and marketers in
58 countries on six continents.

Cyanotech Corporation is a world leader in microalgae-based, high-value nutrition and health products, has recently reported that it had received notice from the Nasdaq Stock Market on June 30, 2010 of full compliance with Listing Rules required for its continued listing on the The Nasdaq Capital Market.

On March 8, 2010, Nasdaq issued a non-compliance notice to the Company given the appointment of David I. Rosenthal as Interim President and CEO and his concurrent resignation from the Audit Committee of the Board of Directors due to his temporary executive position. The non-compliance notice was due to the Board having fewer than three independent directors on its audit committee and having less than a majority of non-executive, independent directors. On March 31, 2010, the Board was restored to compliance upon the resignation from the Board by the prior President and CEO, leaving a majority of non-executive, independent directors plus only two executive directors. On June 23, 2010, the Board of Directors appointed Michael A. Davis, an independent director, to the Audit Committee. Upon its notification of this action to Nasdaq, the Company completed its requirements for return to full compliance.

_________________________________



Reliv International, Inc. ,

Reliv International, Inc., based in Chesterfield, Mo., is a developer, manufacturer and marketer of a proprietary line of nutritional supplements.  Reliv supplements address essential daily nutrition, weight loss and targeted solutions such as energy and performance enhancement, digestive health, women’s health and anti-aging. Reliv sells its products through an international network marketing system of approximately 64,000 independent distributors.

Reliv International, Inc. a nutritionand direct selling company, today reported consolidated net sales of $18.8 million for the second quarter
of 2010, compared to net sales of $20.1 million in the second quarter of last year.  International sales rose 18.7 percent compared to the same quarter in 2009, but U.S. sales were down 9.5 percent in the quarter.

Net income was $206,000 compared to net income of $410,000 in the second quarter of last year.  Diluted earnings per share totaled $0.02 in the second quarter this year compared to $0.03 in the same quarter last year.

U.S. sales for the quarter totaled approximately $15.9 million compared to $17.6 million in the second quarter of 2009.  Sales outside of the U.S. rose to approximately $2.9 million compared to net sales of approximately $2.4 million in last year’s second quarter.  In local currencies,international sales rose 11.3 percent in the second quarter compared to the same quarter last year.  Sales outside of the U.S. account for 15 percent of net sales.










*******************************************
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
*******************************************











THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received twenty five thousand dollars in cash and twenty five thousand dollars in free trading stock from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB)
5:40 AM 7/30 Crown Equity Holdings, Inc. (CRWE.OB) has received fifteen thousand dollars in cash from a third party (PenStox) for (15) days of advertising for NW Tech Capital, Inc. (NWTT.PK)



*******************************************

# # #

Crown Equity Holdings Inc. assists and consults with domestic and foreign companies interested in becoming publicly traded in the U.S. The company designs and manufactures multi-monitor computer systems for financial traders and audio/video professionals.